Amplitude modulation of androgen signaling by c-MYC

Genes and Development

Volumn 27, Issue 7, 2013, Pages 734-748

  Ni, Min ^a,b   Chen, Yiwen ^a,c   Fei, Teng ^a,b   Li, Dan ^a,b   Lim, Elgene ^a,b   Liu, X Shirley ^a,c   Brown, Myles ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

AR; Breast cancer; Cistrome; FOXA1; MYC; TCF7L2

Indexed keywords

ANDROGEN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN MAD1;

AMPLITUDE MODULATION; ARTICLE; BREAST CANCER; CANCER GROWTH; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TRANSCRIPTION INITIATION;

ANDROGENS; BREAST NEOPLASMS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; GENOME-WIDE ASSOCIATION STUDY; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; HUMANS; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN; TRANSCRIPTIONAL ACTIVATION;

EID: 84876217788     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.209569.112     Document Type: Article

References (37)

1. Ayer DE, Kretzner L, Eisenman RN. 1993. Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72: 211-222.
2. Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, Szary AJ, Eeckhoute J, Shao W, Hestermann EV, Geistlinger TR, et al. 2005. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122: 33-43.
3. Chen X, Xu H, Yuan P, Fang F, Huss M, Vega VB, Wong E, Orlov YL, Zhang W, Jiang J, et al. 2008. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133: 1106-1117.
4. Chou CK, Lee DF, Sun HL, Li LY, Lin CY, Huang WC, Hsu JM, Kuo HP, Yamaguchi H, Wang YN, et al. 2009. The suppression of MAD1 by AKT-mediated phosphorylation activates MAD1 target genes transcription. Mol Carcinog 48: 1048-1058.
5. Dang CV. 2012. MYC on the path to cancer. Cell 149: 22-35.
6. Eeckhoute J, Lupien M, Meyer CA, Verzi MP, Shivdasani RA, Liu XS, Brown M. 2009. Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers. Genome Res 19: 372-380.
7. Farmer P, Bonnefoi H, Becette V, Tubiana-Hulin M, Fumoleau P, Larsimont D, Macgrogan G, Bergh J, Cameron D, Goldstein D, et al. 2005. Identification of molecular apocrine breast tumours by microarray analysis. Oncogene 24: 4660-4671.
8. Giese K, Kingsley C, Kirshner JR, Grosschedl R. 1995. Assembly and function of a TCRa enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes Dev 9: 995-1008.
9. Hurley LH, Von Hoff DD, Siddiqui-Jain A, Yang D. 2006. Drug targeting of the c-MYC promoter to repress gene expression via a G-quadruplex silencer element. Semin Oncol 33: 498-512.
10. Kaur M, Cole MD. 2013. MYC acts via the PTEN tumor suppressor to elicit autoregulation and genome-wide gene repression by activation of the Ezh2 methyltransferase. Cancer Res 73: 695-705.
11. Kim J, Chu J, Shen X, Wang J, Orkin SH. 2008. An extended transcriptional network for pluripotency of embryonic stem cells. Cell 132: 1049-1061.
12. Kim J, Woo AJ, Chu J, Snow JW, Fujiwara Y, Kim CG, Cantor AB, Orkin SH. 2010. A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs. Cell 143: 313-324.
13. Levens D. 2010. You don't muck with MYC. Genes Cancer 1: 547-554.
14. Li Z, Van Calcar S, Qu C, Cavenee WK, Zhang MQ, Ren B. 2003. A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc Natl Acad Sci 100: 8164-8169.
15. Lim E, Ni M, Hazra A, Tamimi RM, Brown M. 2012. Elucidating the role of androgen receptor in breast cancer. Clin Investig 2: 1003-1011.
16. Lin CY, Loven J, Rahl PB, Paranal RM, Burge CB, Bradner JE, Lee TI, Young RA. 2012. Transcriptional amplification in tumor cells with elevated c-Myc. Cell 151: 56-67.
17. Liu T, Ortiz JA, Taing L, Meyer CA, Lee B, Zhang Y, Shin H, Wong SS, Ma J, Lei Y, et al. 2011. Cistrome: An integrative platform for transcriptional regulation studies. Genome Biol 12: R83.
18. Love JJ, Li X, Case DA, Giese K, Grosschedl R, Wright PE. 1995. Structural basis for DNA bending by the architectural transcription factor LEF-1. Nature 376: 791-795.
19. Lupien M, Eeckhoute J, Meyer CA, Wang Q, Zhang Y, Li W, Carroll JS, Liu XS, Brown M. 2008. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 132: 958-970.
20. Mao CD, Byers SW. 2011. Cell-context dependent TCF/LEF expression and function: Alternative tales of repression, derepression and activation potentials. Crit Rev Eukaryot Gene Expr 21: 207-236.
21. Ni M, Chen Y, Lim E, Wimberly H, Bailey ST, Imai Y, Rimm DL, Liu XS, Brown M. 2011. Targeting androgen receptor in estrogen receptor-negative breast cancer. Cancer Cell 20: 119-131.
22. Nie Z, Hu G, Wei G, Cui K, Yamane A, Resch W, Wang R, Green DR, Tessarollo L, Casellas R, et al. 2012. c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 151: 68-79.
23. Pomerantz MM, Ahmadiyeh N, Jia L, Herman P, Verzi MP, Doddapaneni H, Beckwith CA, Chan JA, Hills A, Davis M, et al. 2009. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat Genet 41: 882-884.
24. Rhodes DR, Kalyana-Sundaram S, Tomlins SA, Mahavisno V, Kasper N, Varambally R, Barrette TR, Ghosh D, Varambally S, Chinnaiyan AM. 2007. Molecular concepts analysis links tumors, pathways, mechanisms, and drugs. Neoplasia 9: 443-454.
25. Robinson JL, Macarthur S, Ross-Innes CS, Tilley WD, Neal DE, Mills IG, Carroll JS. 2011. Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1. EMBO J 30: 3019-3027.
26. Sekiya T, Zaret KS. 2007. Repression by Groucho/TLE/Grg proteins: Genomic site recruitment generates compacted chromatin in vitro and impairs activator binding in vivo. Mol Cell 28: 291-303.
27. Serandour AA, Avner S, Percevault F, Demay F, Bizot M, Lucchetti-Miganeh C, Barloy-Hubler F, Brown M, Lupien M, Metivier R, et al. 2011. Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers. Genome Res 21: 555-565.
28. Shin H, Liu T, Manrai AK, Liu XS. 2009. CEAS: Cis-regulatory element annotation system. Bioinformatics 25: 2605-2606.
29. Tan SK, Lin ZH, Chang CW, Varang V, Chng KR, Pan YF, Yong EL, Sung WK, Cheung E. 2011. AP-2g regulates oestrogen receptor-mediated long-range chromatin interaction and gene transcription. EMBO J 30: 2569-2581.
30. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, Salzberg SL, Wold BJ, Pachter L. 2010. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 28: 511-515.
31. van Houte L, van Oers A, van de Wetering M, Dooijes D, Kaptein R, Clevers H. 1993. The sequence-specific high mobility group 1 box of TCF-1 adopts a predominantly a-helical conformation in solution. J Biol Chem 268: 18083-18087.
32. Wolfer A, Wittner BS, Irimia D, Flavin RJ, Lupien M, Gunawardane RN, Meyer CA, Lightcap ES, Tamayo P, Mesirov JP, et al. 2010. MYC regulation of a 'poor-prognosis' metastatic cancer cell state. Proc Natl Acad Sci 107: 3698-3703.
33. Woodfield GW, Horan AD, Chen Y, Weigel RJ. 2007. TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling. Cancer Res 67: 8439-8443.
34. Xu J, Sankaran VG, Ni M, Menne TF, Puram RV, Kim W, Orkin SH. 2010. Transcriptional silencing of g-globin by BCL11A involves long-range interactions and cooperation with SOX6. Genes Dev 24: 783-798.
35. Zeller KI, Zhao X, Lee CW, Chiu KP, Yao F, Yustein JT, Ooi HS, Orlov YL, Shahab A, Yong HC, et al. 2006. Global mapping of c-Myc binding sites and target gene networks in human B cells. Proc Natl Acad Sci 103: 17834-17839.
36. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nussbaum C, Myers RM, Brown M, Li W, et al. 2008. Model-based analysis of ChIP-Seq (MACS). Genome Biol 9: R137.
37. Zhu J, Blenis J, Yuan J. 2008. Activation of PI3K/Akt and MAPK pathways regulates Myc-mediated transcription by phosphorylating and promoting the degradation of Mad1. Proc Natl Acad Sci 105: 6584-6589.